509073-62-5

Basic information

• Product Name: TERT-BUTYL 4-(4-NITROBENZOYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE
• Synonyms: TERT-BUTYL 4-(4-NITROBENZOYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE;4-(4-Nitro-benzoyl)-piperazine-1-carboxylic acid tert-butyl ester;tert-Butyl 4-(4-nitrobenzoyl)piperazine-1-carboxylate;1-Piperazinecarboxylic acid, 4-(4-nitrobenzoyl)-, 1,1-diMethylethyl ester;tert-Butyl 4-(4-nitrobenzoyl)
• CAS NO: 509073-62-5
• Molecular Formula: C₁₆H₂₁N₃O₅
• Molecular Weight: 335.36
• Mol File: 509073-62-5.mol
• Article Data: 22

Chemical Properties

• Melting Point: 144
• Boiling Point: 502.8±45.0 °C(Predicted)
• Appearance: /
• Density: 1.267±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -0.49±0.70(Predicted)
• CAS DataBase Reference: TERT-BUTYL 4-(4-NITROBENZOYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL 4-(4-NITROBENZOYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE(509073-62-5)
• EPA Substance Registry System: TERT-BUTYL 4-(4-NITROBENZOYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE(509073-62-5)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 509073-62-5(Hazardous Substances Data)

Usage

General Description

TERT-BUTYL 4-(4-NITROBENZOYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE is a chemical compound that belongs to the class of tetrahydropyrazine carboxylates. It is composed of a tert-butyl group, a 4-(4-nitrobenzoyl) substituent, and a tetrahydro-1(2H)-pyrazinecarboxylate moiety. This chemical compound is used in various industries, including pharmaceuticals and organic synthesis. It can be used as a building block for the synthesis of other organic compounds. Additionally, it may have potential biological or pharmaceutical applications due to its unique structure and properties. However, it is important to handle this chemical with caution and in accordance with safety protocols, as it may pose health and environmental hazards if not used properly.

Upstream product

• 122-04-3 4-nitro-benzoyl chloride 
• 57260-71-6 1-t-Butoxycarbonylpiperazine 
• 62-23-7 4-nitro-benzoic acid 

Downstream Products

• 350684-49-0 4-(4-aminobenzoyl)piperazine-1-carboxylic acid tert-butyl ester 
• 72141-41-4 (4-nitro-phenyl)-piperazin-1-yl-methanone 
• 1622867-09-7 C₂₅H₂₁N₅O₅S 

Relevant articles and documents

Synthesis of novel sulfonamide derivatives containing pyridin-3-ylmethyl 4-(benzoyl)piperazine-1-carbodithioate moiety as potent PKM2 activators

Pyruvate kinase M2 isoform (PKM2) plays a key role in cancer progression through both metabolic and non-metabolic functions, thus it is recognized as a potential target for cancer diagnosis and treatment. In this study, we discovered a sulfonamide-dithiocarbamate compound 8a as a novel PKM2 activator from a random screening of an in-house compound library. Then, a series of lead compound 8a analogs were designed and synthesized for screening as potent PKM2 activators. Among them, compound 8b (AC50 = 0.136 μM) and 8k (AC50 = 0.056 μM) showed higher PKM2 activation activities than positive control NZT (AC50 = 0.228 μM), and they (IC50 50 > 10 μM). Especially, compound 8k inhibited the proliferation of multiple cancer cells, but showed little toxicity on normal cells. In addition, we found that compound 8k inhibit the colony formation of MCF7 cells. Western blot analysis demonstrated that 8k could reduce PKM2 nuclear localization and block the downstream signaling pathway of PKM2, resulting in suppression of tumor cell proliferation. Overall, compound 8k may be a promising candidate for further mechanistic investigation of PKM2 and cancer therapy.

Optimization and SAR research at the piperazine and phenyl rings of JNJ4796 as new anti-influenza A virus agents, part 1

JNJ4796, a small molecule fuse inhibitor targeting the conserved stem region of hemagglutinin, effectively neutralized a broad spectrum of group 1 influenza A virus (IAV), and protected mice against lethal and sublethal influenza challenge after oral admi

Looking toward the Rim of the Active Site Cavity of Druggable Human Carbonic Anhydrase Isoforms

We report the synthesis and biochemical evaluation of a series of substituted 4-(4-aroylpiperazine-1-carbonyl)benzenesulfonamides (5a-s) developed as inhibitors of druggable carbonic anhydrase (CA) isoforms, as tools for the identification of new therapeu